These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9654223)

  • 1. Immediate reproducibility of upper limit of vulnerability measurements in patients undergoing transvenous implantable cardioverter defibrillator implantation.
    Ellenbogen KA; Wood MA; Gilligan DM; Crofts T; London W; McClish D
    J Cardiovasc Electrophysiol; 1998 Jun; 9(6):588-95. PubMed ID: 9654223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm.
    Birgersdotter-Green U; Undesser K; Fujimura O; Feld GK; Kass RM; Mandel WJ; Peter CT; Chen PS
    J Interv Card Electrophysiol; 1999 Jul; 3(2):155-61. PubMed ID: 10387143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing.
    Green UB; Garg A; Al-Kandari F; Ungab G; Tone L; Feld GK
    J Interv Card Electrophysiol; 2003 Feb; 8(1):71-5. PubMed ID: 12652181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of shock waveform on relationship between upper limit of vulnerability and defibrillation threshold.
    Swerdlow CD; Kass RM; O'Connor ME; Chen PS
    J Cardiovasc Electrophysiol; 1998 Apr; 9(4):339-49. PubMed ID: 9581950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs.
    Swerdlow CD; Shehata M; Chen PS
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous implantable defibrillators.
    Martin DJ; Chen PS; Hwang C; Gang ES; Mandel WJ; Peter CT; Swerdlow CD
    J Cardiovasc Electrophysiol; 1997 Mar; 8(3):241-8. PubMed ID: 9083873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative reproducibility of defibrillation threshold and upper limit of vulnerability.
    Swerdlow CD; Davie S; Ahern T; Chen PS
    Pacing Clin Electrophysiol; 1996 Dec; 19(12 Pt 1):2103-11. PubMed ID: 8994950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal strength and number of shocks at upper limit of vulnerability testing required to predict high defibrillation threshold without inducing ventricular fibrillation.
    Takami K; Yoshida A; Fukuzawa K; Takei A; Kiuchi K; Kanda G; Kumagai H; Takami M; Torii-Tanaka S; Itoh M; Imamura K; Fujiwara R; Suzuki A; Nakanishi T; Yamashita S; Matsumoto A; Hirata K
    Circ J; 2013; 77(10):2490-6. PubMed ID: 23877733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
    Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
    J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability.
    Swerdlow CD; Peter CT; Kass RM; Gang ES; Mandel WJ; Hwang C; Martin DJ; Chen PS
    Circulation; 1997 Mar; 95(6):1497-504. PubMed ID: 9118518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of adequate safety margin using single coupling interval-upper limit of vulnerability test.
    Patel MB; Pandya K; Thakur RK
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):95-103. PubMed ID: 24033830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship Between Cardiac Vulnerability and Restitution Properties of the Ventricular Activation Recovery Interval.
    Yamashita S; Yoshida A; Fukuzawa K; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hyogo K; Imada H; Hirata K
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):768-73. PubMed ID: 25810143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions.
    Glikson M; Gurevitz OT; Trusty JM; Sharma V; Luria DM; Eldar M; Shen WK; Rea RF; Hammill SC; Friedman PA
    Am J Cardiol; 2004 Dec; 94(11):1445-9. PubMed ID: 15566924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the upper limit of vulnerability during defibrillator implantation can substitute defibrillation threshold measurement.
    Bessho R; Tanaka S
    Int J Artif Organs; 1998 Mar; 21(3):151-60. PubMed ID: 9622114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The zone of vulnerability to T wave shocks in humans.
    Swerdlow CD; Martin DJ; Kass RM; Davie S; Mandel WJ; Gang ES; Chen PS
    J Cardiovasc Electrophysiol; 1997 Feb; 8(2):145-54. PubMed ID: 9147699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of the upper limit of vulnerability is different for monophasic and biphasic shocks: implications for the determination of the defibrillation threshold.
    Behrens S; Li C; Franz MR
    Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2179-87. PubMed ID: 9309741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cardiac compression on defibrillation efficacy and the upper limit of vulnerability.
    Idriss SF; Anstadt MP; Anstadt GL; Ideker RE
    J Cardiovasc Electrophysiol; 1995 May; 6(5):368-78. PubMed ID: 7551306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of atrial refractoriness to upper and lower limits of vulnerability for atrial fibrillation/flutter following implantable ventricular defibrillator shocks.
    Katz A; Sweeney RJ; Gill RM; Reid PR; Prystowsky EN
    Circulation; 1999 Sep; 100(10):1125-30. PubMed ID: 10477539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of biphasic shock duration on defibrillation threshold with different electrode configurations and phase 2 capacitances: prediction by upper-limit-of-vulnerability determination.
    Schauerte PN; Ziegert K; Waldmann M; Schöndube FA; Birkenhauer F; Mischke K; Grossmann M; Hanrath P; Stellbrink C
    Circulation; 1999 Mar; 99(11):1516-22. PubMed ID: 10086978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.